Literature DB >> 22446103

Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.

Miao Sun1, Gary D Isaacs, Nasun Hah, Nina Heldring, Elizabeth A Fogarty, W Lee Kraus.   

Abstract

Steroid hormone and MAPK signaling pathways functionally intersect, but the molecular mechanisms of this cross talk are unclear. Here, we demonstrate a functional convergence of the estrogen and c-Jun N-terminal kinase 1 (JNK1) signaling pathways at the genomic level in breast cancer cells. We find that JNK1 binds to many promoters across the genome. Although most of the JNK1-binding sites are constitutive, a subset is estrogen regulated (either induced on inhibited). At the estrogen-induced sites, estrogen receptor (ER)α is required for the binding of JNK1 by promoting its recruitment to estrogen response elements or other classes of DNA elements through a tethering mechanism, which in some cases involves activating protein-1. At estrogen-regulated promoters, JNK1 functions as a transcriptional coregulator of ERα in a manner that is dependent on its kinase activity. The convergence of ERα and JNK1 at target gene promoters regulates estrogen-dependent gene expression outcomes, as well as downstream estrogen-dependent cell growth responses. Analysis of existing gene expression profiles from breast cancer biopsies suggests a role for functional interplay between ERα and JNK1 in the progression and clinical outcome of breast cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446103      PMCID: PMC3355551          DOI: 10.1210/me.2011-1158

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  69 in total

1.  Using TESS to predict transcription factor binding sites in DNA sequence.

Authors:  Jonathan Schug
Journal:  Curr Protoc Bioinformatics       Date:  2008-03

Review 2.  Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms.

Authors:  V Pallottini; P Bulzomi; P Galluzzo; C Martini; M Marino
Journal:  Infect Disord Drug Targets       Date:  2008-03

Review 3.  When signaling kinases meet histones and histone modifiers in the nucleus.

Authors:  Sung Hee Baek
Journal:  Mol Cell       Date:  2011-05-06       Impact factor: 17.970

4.  A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells.

Authors:  Nasun Hah; Charles G Danko; Leighton Core; Joshua J Waterfall; Adam Siepel; John T Lis; W Lee Kraus
Journal:  Cell       Date:  2011-05-05       Impact factor: 41.582

5.  Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway.

Authors:  Nina Heldring; Gary D Isaacs; Adam G Diehl; Miao Sun; Edwin Cheung; Jeffrey A Ranish; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2011-02-17

6.  Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.

Authors:  Zeynep Madak-Erdogan; Mathieu Lupien; Fabio Stossi; Myles Brown; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

7.  A chromatin-modifying function of JNK during stem cell differentiation.

Authors:  Vijay K Tiwari; Michael B Stadler; Christiane Wirbelauer; Renato Paro; Dirk Schübeler; Christian Beisel
Journal:  Nat Genet       Date:  2011-12-18       Impact factor: 38.330

Review 8.  Extranuclear steroid receptors: nature and actions.

Authors:  Stephen R Hammes; Ellis R Levin
Journal:  Endocr Rev       Date:  2007-10-04       Impact factor: 19.871

9.  Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes.

Authors:  Raga Krishnakumar; Matthew J Gamble; Kristine M Frizzell; Jhoanna G Berrocal; Miltiadis Kininis; W Lee Kraus
Journal:  Science       Date:  2008-02-08       Impact factor: 47.728

Review 10.  A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis.

Authors:  Miltiadis Kininis; W Lee Kraus
Journal:  Nucl Recept Signal       Date:  2008-02-15
View more
  9 in total

Review 1.  Network Motifs in JNK Signaling.

Authors:  Vasudha Sehgal; Prahlad T Ram
Journal:  Genes Cancer       Date:  2013-09

Review 2.  Chromatin-tethered MAPKs.

Authors:  Aileen M Klein; Elma Zaganjor; Melanie H Cobb
Journal:  Curr Opin Cell Biol       Date:  2013-02-20       Impact factor: 8.382

3.  c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer.

Authors:  Huan He; Indranil Sinha; Rongrong Fan; Lars-Arne Haldosen; Feifei Yan; Chunyan Zhao; Karin Dahlman-Wright
Journal:  Oncogene       Date:  2018-02-22       Impact factor: 9.867

4.  XAF1 destabilizes estrogen receptor α through the assembly of a BRCA1-mediated destruction complex and promotes estrogen-induced apoptosis.

Authors:  Ji-Sun Lim; Kyung-Woo Lee; Kyung-Phil Ko; Seong-In Jeong; Byung-Kyu Ryu; Min-Goo Lee; Sung-Gil Chi
Journal:  Oncogene       Date:  2022-04-16       Impact factor: 9.867

5.  Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.

Authors:  George Notas; Marilena Kampa; Vassiliki Pelekanou; Maria Troullinaki; Yves Jacquot; Guy Leclercq; Elias Castanas
Journal:  Mol Oncol       Date:  2013-02-20       Impact factor: 6.603

6.  Discovery, Annotation, and Functional Analysis of Long Noncoding RNAs Controlling Cell-Cycle Gene Expression and Proliferation in Breast Cancer Cells.

Authors:  Miao Sun; Shrikanth S Gadad; Dae-Seok Kim; W Lee Kraus
Journal:  Mol Cell       Date:  2015-07-30       Impact factor: 17.970

7.  Identification of a potential prognostic lncRNA-miRNA-mRNA signature in endometrial cancer based on the competing endogenous RNA network.

Authors:  Yiwei Wang; Ting Huang; Xiao Sun; Yudong Wang
Journal:  J Cell Biochem       Date:  2019-07-24       Impact factor: 4.429

8.  Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation.

Authors:  Athena Sklias; Andrea Halaburkova; Ludovica Vanzan; Nora Fernandez Jimenez; Cyrille Cuenin; Liacine Bouaoun; Vincent Cahais; Victor Ythier; Aurélie Sallé; Claire Renard; Geoffroy Durand; Florence Le Calvez-Kelm; Rita Khoueiry; Rabih Murr; Zdenko Herceg
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

9.  Lnc-NA inhibits proliferation and metastasis in endometrioid endometrial carcinoma through regulation of NR4A1.

Authors:  Linying Sun; Rongfang Zhou; Jing Dong; Shuang Liu; Yulian Jiao; Laicheng Wang; Shengnan Hu; Pengjuan He; Xiaowen Liu; Xingbo Zhao; Guosheng Jiang; Yueran Zhao
Journal:  J Cell Mol Med       Date:  2019-05-03       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.